These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16864905)

  • 1. Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome.
    Simcić D; Pezelj-Ribarić S; Grzić R; Horvat J; Brumini G; Muhvić-Urek M
    Mediators Inflamm; 2006; 2006(1):54632. PubMed ID: 16864905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines.
    Pekiner FN; Gümrü B; Demirel GY; Ozbayrak S
    J Oral Pathol Med; 2009 Mar; 38(3):269-75. PubMed ID: 19141055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
    Suh KI; Kim YK; Kho HS
    Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiorphin in burning mouth syndrome patients: a case-control study.
    Salarić I; Sabalić M; Alajbeg I
    Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burning mouth syndrome: a therapeutic approach involving mechanical salivary stimulation.
    de Souza FT; Amaral TM; dos Santos TP; Abdo EN; Aguiar MC; Teixeira AL; Kummer AM; Abreu MH; Silva TA
    Headache; 2012 Jun; 52(6):1026-34. PubMed ID: 22084903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics.
    Ji EH; Diep C; Liu T; Li H; Merrill R; Messadi D; Hu S
    Mol Pain; 2017 Jan; 13():1744806916686796. PubMed ID: 28326926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy.
    Pezelj-Ribarić S; Kqiku L; Brumini G; Urek MM; Antonić R; Kuiš D; Glažar I; Städtler P
    Lasers Med Sci; 2013 Jan; 28(1):297-301. PubMed ID: 22773117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome.
    Boras VV; Brailo V; Lukac J; Kordić D; Blazić-Potocki Z
    Oral Dis; 2006 May; 12(3):353-5. PubMed ID: 16700748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1 and Toll-like receptor-2 expression in burning mouth syndrome and oral lichen planus.
    Kho HS; Chang JY; Kim YY; Kim Y
    Arch Oral Biol; 2013 Jul; 58(7):837-42. PubMed ID: 23411403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study.
    Borelli V; Marchioli A; Di Taranto R; Romano M; Chiandussi S; Di Lenarda R; Biasotto M; Zabucchi G
    Oral Dis; 2010 May; 16(4):365-74. PubMed ID: 20233324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile.
    de Moura SA; de Sousa JM; Lima DF; Negreiros AN; Silva Fde V; da Costa LJ
    Gerodontology; 2007 Sep; 24(3):173-6. PubMed ID: 17696895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced sialyl-Lewis
    Acharya S; Jin C; Bylund J; Shen Q; Kamali-Moghaddam M; Jontell M; Carlén A; Karlsson NG
    Mol Omics; 2019 Oct; 15(5):331-339. PubMed ID: 31414088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential salivary and serum biomarkers for burning mouth syndrome and their relationship with anxiety/depression.
    Zhang Y; Ye S; Zhang Y; Sun H; Zhao X; Shen X; Wu L
    J Dent Sci; 2024 Apr; 19(2):1052-1060. PubMed ID: 38618099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of interleukin-1β and MUC7 genes in burning mouth syndrome.
    Kim MJ; Kim J; Chang JY; Kim YY; Kho HS
    Clin Oral Investig; 2017 Apr; 21(3):949-955. PubMed ID: 27246755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of openness personality trait with stress-related salivary biomarkers in burning mouth syndrome.
    de Souza FT; Kummer A; Silva ML; Amaral TM; Abdo EN; Abreu MH; Silva TA; Teixeira AL
    Neuroimmunomodulation; 2015; 22(4):250-5. PubMed ID: 25322841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral and trace element analysis of saliva from patients with BMS: a cross-sectional prospective controlled clinical study.
    López-Jornet P; Juan H; Alvaro PF
    J Oral Pathol Med; 2014 Feb; 43(2):111-6. PubMed ID: 23869755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein composition, adhesion, and agglutination properties of saliva in burning mouth syndrome.
    Tammiala-Salonen T; Söderling E
    Scand J Dent Res; 1993 Aug; 101(4):215-8. PubMed ID: 8362199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics of the acid-soluble fraction of whole and major gland saliva in burning mouth syndrome patients.
    Cabras T; Manconi B; Castagnola M; Sanna MT; Arba M; Acharya S; Ekström J; Carlén A; Messana I
    Arch Oral Biol; 2019 Feb; 98():148-155. PubMed ID: 30496935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Salivary Cortisol and α-amylase Levels and Psychological Profiles in Patients with Burning Mouth Syndrome.
    Nosratzehi T; Salimi S; Parvaee A
    Spec Care Dentist; 2017 May; 37(3):120-125. PubMed ID: 28112423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome.
    Tvarijonaviciute A; Aznar-Cayuela C; Rubio CP; Ceron JJ; López-Jornet P
    J Oral Pathol Med; 2017 May; 46(5):387-392. PubMed ID: 27862315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.